MAOB

(redirected from Monoamine Oxidase Type B)
AcronymDefinition
MAOBMonoamine Oxidase Type B (Parkinson's disease medication)
MAOBMaster of Arts in Organizational Behavior (various schools)
References in periodicals archive ?
The data from these two Phase III trials demonstrated that opicapone improved motor fluctuations in levodopa-treated patients regardless of concomitant dopamine agonist or monoamine oxidase type B inhibitors used.
History of deprenyl--the first selective inhibitor of monoamine oxidase type B.
Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder," Biomarkers, vol.
The Management of Early Parkinson's disease (11) includes levodopa, dopamine agonists or monoamine oxidase type B (MAOB) inhibitors (Table 2).
EVT 302 compound targets monoamine oxidase type B, or MAO-B, an enzyme that breaks down dopamine in the brain and contributes to the production of free radicals, which may contribute to the spread of the disease.
Rasagiline--a new molecular entity that was approved in Europe and Israel last year--inhibits monoamine oxidase type B (MAO-B).
Researchers have looked at 17 trials involving drugs called monoamine oxidase type B inhibitors (MAOBIs), used to slow the progression of Parkinson's.
Researchers looked at 17 trials of a group of drugs called monoamine oxidase type B inhibitors (MAOBIs), which are used to slow the progression of Parkinson's.
Researchers looked at 17 trials involving monoamine oxidase type B inhibitors, used to slow the progression of the disease.
Researchers at Birmingham University looked at 17 trials involving a group of drugs called monoamine oxidase type B inhibitors (MAOBIs), which are used to slow the progression of Parkinson's.
The researchers assessed 321 patients in remission from major depressive disorder from previous treatment with a patch containing the selective monoamine oxidase type B inhibitor selegiline.